Half-year report · HY
3154.TEDINET S100XKN4
Period2025-07-01 → 2025-12-31
Filed2026-02-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥149.2bn | 2025-07-01 → 2025-12-31 | Cons. | Net sales |
| Revenue | ¥288.7bn | 2024-07-01 → 2025-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥142.7bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Operating income | ¥585m | 2025-07-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | ¥751m | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | ¥817m | 2025-07-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.4bn | 2024-07-01 → 2025-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥983m | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥803m | 2025-07-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥983m | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥387m | 2025-07-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.4bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥407m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥388m | 2025-07-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | ¥407m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥127.6bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥113.0bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥119.8bn | at 2024-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥107.4bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥92.5bn | at 2025-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥20.3bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥20.5bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥20.0bn | at 2024-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥19.2bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥14.3bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥19.2bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.3bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.0bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.5bn | at 2024-06-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥1.6bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥7.0bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.5bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥605m | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.5bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.4bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥7.1bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.5bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥586m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥17.41 | 2025-07-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥61.91 | 2024-07-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.32 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥17.39 | 2025-07-01 → 2025-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥61.85 | 2024-07-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥18.32 | 2024-07-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 15.9% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 18.1% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 16.7% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-07-01 → 2025-12-31 | −¥9m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-07-01 → 2025-12-31 | −¥9m |
| Reconciling Itemsreconciling | segment profit | 2025-07-01 → 2025-12-31 | −¥4.2bn |
| Medical Equipment Salesreportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥146.1bn |
| Medical Equipment Salesreportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥146.1bn |
| Medical Equipment Salesreportable segment | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥9m |
| Medical Equipment Salesreportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥4.5bn |
| Nursing Care And Welfarereportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥3.1bn |
| Nursing Care And Welfarereportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥3.1bn |
| Nursing Care And Welfarereportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥308m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-07-01 → 2025-12-31 | ¥149.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-07-01 → 2025-12-31 | ¥149.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥9m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-07-01 → 2025-12-31 | ¥4.8bn |
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥9m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥9m |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥4.5bn |
| Medical Equipment Salesreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥139.7bn |
| Medical Equipment Salesreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥139.7bn |
| Medical Equipment Salesreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥9m |
| Medical Equipment Salesreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥5.0bn |
| Nursing Care And Welfarereportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥3.0bn |
| Nursing Care And Welfarereportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥3.0bn |
| Nursing Care And Welfarereportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥250m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2024-12-31 | ¥142.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2024-12-31 | ¥142.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥9m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2024-12-31 | ¥5.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 563
| Item | Context | Value | Unit |
|---|---|---|---|
| Extraordinary income | Prior1InterimDuration | 2009000 | JPY |
| Extraordinary income | InterimDuration | 6115000 | JPY |
| Loss on sales of noncurrent assets el | Prior1InterimDuration | 131000 | JPY |
| Loss on sales of noncurrent assets el | InterimDuration | － | JPY |
| Loss on retirement of noncurrent assets el | Prior1InterimDuration | 1860000 | JPY |
| Loss on retirement of noncurrent assets el | InterimDuration | 16361000 | JPY |
| Impairment loss el | Prior1InterimDuration | － | JPY |
| Impairment loss el | InterimDuration | 3801000 | JPY |
| Extraordinary loss | Prior1InterimDuration | 1992000 | JPY |
| Extraordinary loss | InterimDuration | 20162000 | JPY |
| Income before income taxes | Prior1InterimDuration | 983212000 | JPY |
| Income before income taxes | InterimDuration | 803258000 | JPY |
| Income taxes current | Prior1InterimDuration | 446893000 | JPY |
| Income taxes current | InterimDuration | 357285000 | JPY |
| Income taxes deferred | Prior1InterimDuration | 129567000 | JPY |
| Income taxes deferred | InterimDuration | 57938000 | JPY |
| Income taxes | Prior1InterimDuration | 576460000 | JPY |
| Income taxes | InterimDuration | 415223000 | JPY |
| Profit loss | Prior1InterimDuration | 406751000 | JPY |
| Profit loss | InterimDuration | 388034000 | JPY |
| Profit loss attributable to non controlling interests | Prior1InterimDuration | － | JPY |
| Profit loss attributable to non controlling interests | InterimDuration | 708000 | JPY |
| Profit loss attributable to owners of parent | Prior1InterimDuration | 406751000 | JPY |
| Profit loss attributable to owners of parent | InterimDuration | 387326000 | JPY |
| Profit loss | Prior1InterimDuration | 406751000 | JPY |
| Profit loss | InterimDuration | 388034000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1InterimDuration | 270811000 | JPY |
| Valuation difference on available for sale securities net of tax oci | InterimDuration | -146099000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1InterimDuration | 1243000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | InterimDuration | 1495000 | JPY |
| Other comprehensive income | Prior1InterimDuration | 272054000 | JPY |
| Other comprehensive income | InterimDuration | -144604000 | JPY |
| Comprehensive income | Prior1InterimDuration | 678805000 | JPY |
| Comprehensive income | InterimDuration | 243430000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1InterimDuration | 678805000 | JPY |
| Comprehensive income attributable to owners of the parent | InterimDuration | 242721000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1InterimDuration | － | JPY |
| Comprehensive income attributable to non controlling interests | InterimDuration | 708000 | JPY |
| Income before income taxes | Prior1InterimDuration | 983212000 | JPY |
| Income before income taxes | InterimDuration | 803258000 | JPY |
| Depreciation and amortization ope cf | Prior1InterimDuration | 855956000 | JPY |
| Depreciation and amortization ope cf | InterimDuration | 920117000 | JPY |
| Amortization of goodwill ope cf | Prior1InterimDuration | 169689000 | JPY |
| Amortization of goodwill ope cf | InterimDuration | 149689000 | JPY |
| Impairment loss ope cf | Prior1InterimDuration | － | JPY |
| Impairment loss ope cf | InterimDuration | 3801000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1InterimDuration | 62839000 | JPY |
| Increase decrease in net defined benefit liability ope cf | InterimDuration | 56222000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1InterimDuration | 8697000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | InterimDuration | 19316000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |